Shuibing Chen

In this enlightening conversation, Dr. Shuibing Chen, a stem cell biologist at Weill Cornell Medical College, dives into cutting-edge research on diabetes. She discusses her use of CRISPR and human stem cells to model diabetes, focusing on gene-specific drug candidates. Chen reveals her team's findings on how specific gene knockouts impact insulin secretion and beta cell function. She also shares insights from a drug screen identifying an FDA-approved compound that could help rescue beta cell dysfunction, paving the way for personalized therapies.